Anthony Propst MD provides world-class fertility treatment
- For hopeful parents who are struggling to conceive, Anthony Propst MD provides a ray of hope. Our Austin fertility doctor offers a wealth of experience and knowledge in reproductive medicine, and he delivers exceptional fertility care with compassion and understanding.
When he isn’t treating his patients at Texas Fertility Center (TFC), this renowned fertility doctor performs game-changing research to make fertility care safer and more effective. He also had an honorable career with the United States Air Force (USAF) before retiring at the rank of colonel.
Dr. Propst is a highly respected reproductive endocrinologist
Originally from North Carolina, Anthony Propst MD received a U.S. Congressional appointment to the United States Air Force Academy and he attended medical school at the University of North Carolina School of Medicine.
He completed his residency in Obstetrics and Gynecology at the David Grant USAF Medical Center in California. After that, our Austin fertility doctor completed his fellowship in Reproductive Endocrinology and Infertility at Brigham and Women’s Hospital at Harvard Medical School.
Anthony Propst MD is very active in the reproductive medicine community
Anthony Propst MD joined TFC in 2013 after retiring from the USAF after 21 years of service. During his military career, he was the chief of reproductive endocrinology at Wilford Hall USAF Medical Center in San Antonio and at Keesler USAF Medical Center in Biloxi, Mississippi. He is a former chief consultant to the USAF Surgeon General for Obstetrics and Gynecology.
As an Austin fertility doctor, he now diagnoses and provides basic and advanced treatments to women and men who are struggling with infertility.
- Ovulation induction
- Intrauterine insemination (IUI)
- In vitro fertilization (IVF)
- Intracytoplasmic sperm injection (ICSI)
- Donor sperm, egg and embryo services
- Egg freezing
In addition to these treatments, Anthony Propst MD also performs robotic surgery to help correct structural abnormalities that may prevent pregnancy.
Anthony Propst MD is a member of the Practice Committee of the Society for Assisted Reproduction, and he has authored dozens of research articles and multiple book chapters.
To schedule an appointment with Anthony Propst MD, contact us. See how world-class fertility care can help you bring home a healthy baby.
Meet Dr. Tony Propst
Anthony Propst M.D. fertility videos
Dr. Propst’s Fertility Research
|2015||Devine K, Mumford SL, Wu M, DeCherney AH, Hill MJ, Propst A. Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Fertil Steril.2015;104:612-19.|
|2015||Devine K, Mumford SL, Goldman KN, Hodes-Wertz B, Druckenmiller S, Propst AM, Noyes N. Baby budgeting: oocyte cryopreservation in women delaying reproduction can reduce cost per live birth. Fertil Steril. 2015;103:1446-53.|
|2015||Connell MT, Szatkowski JM, Terry N, DeCherney AH, Propst AM, Hill MJ. Timing luteal support in assisted reproductive technology: a systematic review. Fertil Steril. 2015;103:939-946.|
|2015||Whitehurst SV, Lockrow EG, Lendvay TS, Propst AM, Dunlow SG, Rosemeyer CJ, Gobern JM, White LW, Skinner A, Buller JL. Comparison of two simulation systems to support robotic-assisted surgical training: a pilot study (Swine model). J Minim Invasive Gynecol. 2015;22:483-8.|
|2014||Levy G, Hill M, Beall S, Pilgrim JD, Payson M, Propst A. Falling estradiol levels on day after human chorionic gonadotropin administration in assisted reproductive technology cycles are not predictive of decreasing oocyte maturity or pregnancy rates. J Reprod Med. 2014;59:255-9.|
|2013||Hill MJ, Whitcomb BW, Lewis TD, Wu M, Terry N, DeCherney AH, Levens ED, Propst AM. Progesterone luteal support after ovulation induction and intrauterine insemination: a systematic review and meta-analysis. Fertil Steril 2013;100:1373-80|
|2012||Royster GD, Retzloff MG, Robinson RD, King JA, Propst AM. Effect of length of controlled ovarian hyperstimulation using a gonadotropin-releasing hormone antagonist on in vitro fertilization pregnancy rates. J Reprod Med. 2012;57(9-10):415-20.|
|2012||Wu M, Henne M, Propst A. Tax Credits, insurance, and in vitro fertilization in the military. Military Medicine 2012;177(6):745-7.|
|2011||Propst AM, Hill MJ, Bates GW, Palumbo M, Van Horne AK, Retzloff MG. Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration. Fertil Steril 2011;96(4):898-904.|
|2011||Fausett MB, Propst AM, Van Doren K, Clark BT. How To Develop An Effective Obstetric Checklist. Am J Obstet Gynecol, 2011;205(3):165-70.|
|2009||Fritz MA, Ory SJ, Barnhart KT, Catherino WH, Cedars MI, Collins J, Goldberg JM, Gracia C, Licht M, Liu JH, Racowsky C, Schering-Plough, Schattman G, Schering-Plough,Thomas MA, Rebar RW, La Barbera AR, Schattman G, Schering-Plough, Battaglia D, Propst A, Reed M, Sakkas D, Sharara F, Schering-Plough, Vernon M, Widra E. Practice Committee of the American Society for Reproductive Medicine; Practice Committee of the Society for Assisted Reproductive Technology. Guidelines on number of embryos transferred. Fertil Steril 2009;92(5):1518-9.|
|2009||Beesley R, Robinson R, Propst A, Arthur N, Retzloff M. Impact of day 3 or day 5 embryo transfer on pregnancy rates and multiple gestations. Fertil Steril 2009;91(5):1717-20.|